Runping Liu
Impact in
- Hepatology top 1%
- Liver physiology and pathology
- Pharmacology top 0.5%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Natural product bioactivities and synthesis 7
- Epidemiology 29
- Liver Disease Diagnosis and Treatment 22
- Co-authors
- Xiaojiaoyang Li (62 shared papers)Huiping Zhou (24 shared papers)Rong Sun (17 shared papers)Phillip B. Hylemon (20 shared papers)Emily C. Gurley (12 shared papers)William M. Pandak (10 shared papers)Luyong Zhang (12 shared papers)Nana Huang (8 shared papers)
- Journals
- Hepatology (10 papers)Phytomedicine (7 papers)Journal of Ethnopharmacology (7 papers)Acta Pharmacologica Sinica (5 papers)Chinese Journal of Natural Medicines (4 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Runping Liu
96 papers receiving 3.7k citations
Runping Liu's Hit Papers
Peers
Comparison fields: 5 of 121
- Hepatology 554
- Pharmacology 421
- Cancer Research 471
- Epidemiology 1.1k
- Oncology 555
Countries citing papers authored by Runping Liu
This map shows the geographic impact of Runping Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runping Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runping Liu more than expected).
Fields of papers citing papers by Runping Liu
This network shows the impact of papers produced by Runping Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runping Liu. The network helps show where Runping Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Runping Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Natural products in licorice for the therapy of liver diseases: Progress and future opportunities Hit paper breakdown → | 2019 | 220 |
| 2 | 2017 | 184 | |
| 3 | 2019 | 183 | |
| 4 | 2018 | 174 | |
| 5 | 2014 | 167 | |
| 6 | 2014 | 148 | |
| 7 | 2014 | 145 | |
| 8 | 2018 | 129 | |
| 9 | 2019 | 110 | |
| 10 | 2014 | 102 | |
| 11 | 2020 | 94 | |
| 12 | 2017 | 93 | |
| 13 | 2017 | 93 | |
| 14 | 2016 | 92 | |
| 15 | 2019 | 85 | |
| 16 | 2020 | 80 | |
| 17 | 2021 | 80 | |
| 18 | 2015 | 72 | |
| 19 | 2021 | 60 | |
| 20 | 2020 | 60 |
About Runping Liu
Runping Liu is a scholar working on Molecular Biology, Epidemiology, Oncology, Hepatology and Surgery, having authored 103 papers that have together received 3.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (22 papers), Drug Transport and Resistance Mechanisms (10 papers), Liver Disease and Transplantation (8 papers), Liver physiology and pathology (7 papers), Natural product bioactivities and synthesis (7 papers), interferon and immune responses (6 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Liver Diseases and Immunity (6 papers). The work is most often cited by research in Hepatology (554 citations), Pharmacology (421 citations), Cancer Research (471 citations), Epidemiology (1.1k citations) and Oncology (555 citations). Runping Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiaojiaoyang Li, Huiping Zhou, Rong Sun, Phillip B. Hylemon, Emily C. Gurley, William M. Pandak, Luyong Zhang, Nana Huang, Jasmohan S. Bajaj and Guan‐Hua Lai. Their work appears in journals such as Hepatology, Phytomedicine, Journal of Ethnopharmacology, Acta Pharmacologica Sinica and Chinese Journal of Natural Medicines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.